Horizontal transmission of a human rotavirus vaccine strain-A randomized, placebo-controlled study in twins

Vaccine

Volumn 29, Issue 51, 2011, Pages 9508-9513

  Rivera, Luis ^a   Peña, Lourdes Mendez ^a   Stainier, Isabelle ^b   Gillard, Paul ^b   Cheuvart, Brigitte ^b   Smolenov, Igor ^b   Ortega Barria, Eduardo ^c   Han, Htay Htay ^b  

^a Hospital Maternidad Nuestra Sra de la Altagracia   (Dominican Republic)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^c GSK   (Brazil)

Author keywords

Horizontal transmission; HRV; Indirect protection; Twins

Indexed keywords

IMMUNOGLOBULIN A; PLACEBO; ROTAVIRUS VACCINE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; GASTROENTERITIS; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HYBRIDIZATION; IMMUNOGENICITY; INFANT; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS INFECTION; SEROCONVERSION; TWINS; VIRUS GENOME; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; FECES; FEMALE; GENETIC VARIATION; HUMANS; IMMUNOGLOBULIN A; INFANT; MALE; PLACEBOS; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEQUENCE ANALYSIS, RNA; TWINS; VIRUS SHEDDING;

EID: 81955161897     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.015     Document Type: Article

References (19)

1. Butz A.M., Fosarelli P., Dick J., Cusack T., Yolken R. Prevalence of rotavirus on high risk fomites in day care facilities. Pediatrics 1993, 92:202-205.
2. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among, children. Recommendations of the Advisory Committee on Immunization Practices (ACIP), Summary. MMWR Morb Mortal Wkly Rep 1999, 48:1-23.
3. Santosham M., Yolken R.H., Wyatt R.G., Bertrando R., Black R.E., Spira W.M., et al. Epidemiology of rotavirus diarrhea in a prospectively monitored American Indian population. J Infect Dis 1985, 152:778-783.
4. Dennehy P.H. Transmission of rotavirus and other enteric pathogens in the home. Pediatr Infect Dis J 2000, 19:S103-S105.
5. Parashar U.D., Alexander J.P., Glass R.I. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2006, 55:1-13.
6. Phua K.B., Quak S.H., Lee B.W., Emmanuel S.C., Goh P., Han H.H., et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis 2005, 192:S6-S16.
7. Anderson E.J. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis 2008, 8:642-649.
8. Kew O.M., Wright P.F., Agol V.I., Delpeyroux F., Shimizu H., Nathanson N., et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 2004, 82:16-23.
9. Dennehy P.H., Goveia M.G., Dallas M.J., Heaton P.M. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine. Int J Infect Dis 2007, 11:S36-S42.
10. Linhares A.C., Velázquez F.R., Pérez-Schael I., Sáez-Llorens X., Abate H., Espinoza F., et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomized, double-blind, placebo-controlled phase III study. Lancet 2008, 371:1181-1189.
11. van Doorn L.J., Kleter B., Hoefnagel E., Stainier I., Poliszczak A., Colau B., et al. Detection and genotyping of human rotavirus VP4 and VP7 genes by reverse transcriptase PCR and reverse hybridization. J Clin Microbiol 2009, 47:2704-2712.
12. Bernstein D.I., Smith V.E., Sherwood J.R., Schiff G.M., Sander D.S., DeFeudis D., et al. Safety and immunogenicity of a live attenuated human rotavirus 89-12 vaccine. Vaccine 1998, 16:381-387.
13. Bernstein D.I., Sack D.A., Rothstein E., Reisinger K., Smith V.E., O'Sullivan D., et al. Efficacy of live attenuated human rotavirus vaccine 89-12 in infants: a randomized placebo-controlled trial. Lancet 1999, 354:287-290.
14. Clopper C.J., Pearson E. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934, 26:404-413.
15. Dennehy P.H., Brady R.C., Halperin S.A., Ward R.L., Alvey J.C., Fischer F.H., et al. Comparative evaluation of safety and immunogenicity of two doses of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J 2005, 24:481-488.
16. Cassart J.P., Poliszczak A., Debrus S., Lecomte C., Vinals C., De Vos B., et al. The human rotavirus RIX4414 vaccine strain is genetically stable along the production process from seed to final vaccine. 9th dsRNA Virus Meeting 2006.
17. Perez-Schael I., Guntinal M.J., Perez M., Pagone V., Rojas A.M., González R., et al. Efficacy of the rhesus rotavirus based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997, 337:1181-1187.
18. Tregnaghi M.W., Abate H.J., Valencia A., Lopez P., Da Silveira T.R., Rivera L., et al. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America. Pediatr Infect Dis J 2011, 30(6):e103-e108.
19. Madhi S.A., Cunliffe N.A., Steele D., Witte D., Kirsten M., Louw C., et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010, 362(4):289-298.